Microbiology & Toxicology Testing
Wickham Laboratories is a GMP/GLP compliant laboratory with over 50 years of global experience in specialised pharmaceutical and medical device testing in the fields of microbiology and toxicology. Conducting business with clients worldwide, we have the capability to offer solutions to microbiology development projects from early stage to product release as well as routine product testing and toxicology services.
Our approach is to listen and understand your outsourcing requirement, and then translate this information into an effective plan to fully address your testing needs. Using harmonised methods compliant with Ph. Eur, USP, JP and ISO standards, the combined expertise of our laboratory technicians and managers enables us to be fully conversant with regulatory expectations.
Our mission is to be the partner of choice for contract research outsourcing and we aim to offer only the highest possible level of quality and standards for our customers. We are routinely inspected by the MHRA and FDA as well as other global regulatory authorities, and offer the opportunity for clients to conduct audits on a regular basis. We are proud of how our services are recognised in the industry and our ability to deliver consistent, high quality testing no matter what the laboratory discipline.
Contact Details:
Company name: Wickham Laboratories Limited
Website: www.wickhamlabs.co.uk
E-mail: mail@wickhamlabs.co.uk
A Discussion: In Vitro Release Testing and Its Application and Use in Generic Topical
December 18th 2024Lucy Zhou, Director of Skin Lab at CPL, discusses the importance and applications for utilizing in vitro Release Testing during development of generic topical drug compounds. Lucy dicusses how IVRT can play a critical role by saving cost and time during product development and the techniques and applications for using in vitro testing to achieve desired product outcomes.
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.
